Loop Industries, Inc.

Loop Industries presents a distressed capital structure characterized by a negative stockholders’ equity of $-12.0 million and total liabilities of $18.7 million against total assets of $6.7 million. The current ratio stands at 0.68, indicating that current liabilities of $3.2 million exceed current assets of $2.2 million. Cash and equivalents total $1.1 million, which is insufficient to cover the $3.0 million in total debt (long-term $2.2 million + short-term $0.8 million). The company reports a net loss of $3.4 million for the quarter, with operating cash flow negative at $-1.2 million.

Profitability metrics are deeply negative, with a return on assets of -1.83% and a return on equity of 1.02% (distorted by negative equity). The company generated only $0.2 million in revenue for the quarter, primarily from services, while incurring $2.6 million in total expenses, including $0.96 million in R&D and $1.6 million in G&A. The gross margin on services is effectively zero, as cost of services equals revenue.

Revenue concentration is high in the services segment, which accounted for $0.18 million of the $0.18 million total revenue, while product revenue was negligible. The company has no disclosed geographic revenue breakdown in the provided snapshot, but filings reference operations in Canada and Europe through subsidiaries like Infinite Loop Europe and Ester Loop Infinite Technologies.

Growth trajectory is stagnant, with quarterly revenue declining from $0.25 million in Q1 2025 to $0.18 million in Q1 2026. The company has not yet achieved commercial-scale production, relying on engineering services and licensing for minimal cash inflow. Net loss remained relatively flat at $-3.4 million year-over-year, indicating persistent burn without revenue scaling.

Risk factors are severe, with high liquidity risk and medium dilution risk flagged. Filings explicitly reference going-concern or substantial-doubt language, citing the need for additional funding to continue operations. The company faces listing deficiency on Nasdaq, having traded below $1.00 for 32 consecutive days, with a cure deadline of January 18, 2027.

Recent events include the filing of Q1 2026 results highlighting the going-concern warning and the continuation of the Nasdaq bid-price deficiency cure period. Analyst estimates suggest a mean price target of $4.55, implying significant upside from the current $0.82 market price, but this is contingent on successful capital raises and commercialization milestones.

Loop Industries, Inc. (LOOP) has undergone a comprehensive revision of its internal analytical framework, with significant updates to its business summary, key takeaways, and overall conclusion. These modifications, sourced from the ha_light_thesis, represent a medium-severity shift in the company's narrative structure, indicating a fundamental reassessment of its operational or strategic positioning. The most notable aspect of this update is the expansion of the company's key takeaways, which saw an addition of eight new points alongside the removal of five. This net increase suggests a broadening of the factors considered material to Loop's performance, potentially reflecting new developments or a more granular view of its business dynamics. Despite these internal revisions, the broader market and analyst landscape for Loop remains static. The company currently has no analyst coverage, no index memberships, and no reported officers in the available data, while maintaining a top holder count of ten. This lack of external validation or coverage underscores the isolated nature of the recent analytical changes. The significance of these updates lies in the complete overhaul of the company's narrative and conclusion, with similarity scores dropping to 0.013 for both fields. This drastic divergence from prior analysis implies that Loop's strategic outlook or business model has been redefined in the eyes of its internal evaluators, even as external market signals remain absent.

Analysts project 452% upside to a $4.55 mean price target, rating the stock a strong buy.

Return on equity of 1.02% ranks best in class among 29 commodity and specialty chemical peers.

Debt-to-equity ratio of -0.25 is best in class, significantly lower than the peer median of 0.38.

Cash conversion metric of 0.82 exceeds the cohort median of -0.09, indicating superior relative cash generation.

Net margin of -23.9% places the company in the bottom quartile of its 31-member peer cohort.

The company faces high liquidity risk and medium dilution risk according to identified risk flags.

Return on assets of -1.83% indicates inefficient use of assets to generate profits relative to the balance sheet.

Negative book value of $13.7 million suggests equity erosion, complicating valuation based on traditional asset metrics.

Current ratio of 1.31 indicates limited short-term liquidity buffer to cover immediate liabilities.

Revenue $252.0k; Net margin -2639.3%.

• ▍Revenue $252.0k
• ▍Net margin -2639.3%

Revenue $514.0k; Net margin -2392.8%.

• ▍Revenue $514.0k
• ▍Net margin -2392.8%

Revenue $10.9M; Net margin -138.3%.

• ▍Revenue $10.9M
• ▍Net margin -138.3%

Revenue $10.9M; Net margin -138.3%.

• ▍Revenue $10.9M
• ▍Net margin -138.3%

Revenue $153.0k; Net margin -13782.4%.

• ▍Revenue $153.0k
• ▍Net margin -13782.4%